Cargando…
The pharmacokinetics of intranasal droperidol in volunteers characterised via population modelling
BACKGROUND: Droperidol is used parenterally to treat nausea and vomiting, migraine and acute behavioural disturbance. Intranasal use is not reported for droperidol. Intranasal drug administration reduces need for intravenous line placement and risk of needle-stick. OBJECTIVE: To model population pha...
Autores principales: | Cooper, Isabelle, Landersdorfer, Cornelia B, St John, Ashley Gordon, Graudins, Andis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295742/ https://www.ncbi.nlm.nih.gov/pubmed/30574300 http://dx.doi.org/10.1177/2050312118813283 |
Ejemplares similares
-
Pharmacokinetics of intranasal amiloride in healthy volunteers
por: Yellepeddi, Venkata K., et al.
Publicado: (2023) -
Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics
por: Bulitta, Jürgen B., et al.
Publicado: (2019) -
Ondansetron-droperidol combination vs. ondansetron or droperidol monotherapy in the prevention of postoperative nausea and vomiting
por: Matsota, Paraskevi, et al.
Publicado: (2015) -
Novel Population Pharmacokinetic Approach to Explain the Differences between Cystic Fibrosis Patients and Healthy Volunteers via Protein Binding
por: Shah, Nirav R., et al.
Publicado: (2019) -
The PICHFORK (Pain InCHildren Fentanyl OR Ketamine) trial comparing the efficacy of intranasal ketamine and fentanyl in the relief of moderate to severe pain in children with limb injuries: study protocol for a randomized controlled trial
por: Graudins, Andis, et al.
Publicado: (2013)